Nkarta announced its participation in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference. President Nadir Mahmood will take part in a fireside chat at 2 p.m. ET on Tuesday, June 30th, to share updates on the company’s investigational CAR-NK cell therapy for B cell-mediated autoimmune diseases. A simultaneous webcast will be available on the investors section of Nkarta’s website, with a replay archived for approximately 90 days.
Nkarta IncCompany participation in a conference is a routine event; no material news disclosed.